BREAKING NEWS APRIL 15, 2026 - In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500
Shoulder recovery often requires careful attention to volume, scapular control, and progressive exposure to the movements that initially triggered symptoms
If youre ready to start with an oral capsule, BPC Rapid Pro is worth a look
Low B12 can cause issues with anaemia, fatigue, and lack of focus
Jankowski V, Vanholder R, van der GM, Tolle M, Karadogan S, Gobom J, Furkert J, Oksche A, Krause E, Tran TN, Tepel M, Schuchardt M, Schluter H, Wiedon A, Beyermann M, Bader M, Todiras M, Zidek W, Jankowski J